Download PDF
Thromb Haemost 1992; 67(01): 172-175
DOI: 10.1055/s-0038-1648401
Original Articles
Schattauer GmbH Stuttgart

Aprotinin Does Not Inhibit the Release of PGI2 or vWF from Cultured Human Endothelial Cells

B D Royston
1   The Division of Anaesthesia, Harrow, Middlesex, England
,
D Royston
*   Section of Vascular Biology, Clinical Research Centre, Harrow, Middlesex, England
,
S B Coade
*   Section of Vascular Biology, Clinical Research Centre, Harrow, Middlesex, England
,
D M L Morgan
*   Section of Vascular Biology, Clinical Research Centre, Harrow, Middlesex, England
,
J D Pearson
*   Section of Vascular Biology, Clinical Research Centre, Harrow, Middlesex, England
› Author Affiliations
Further Information

Publication History

Received 12 February 1991

Accepted after revision 24 July 1991

Publication Date:
02 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The release of prostacyclin (PGI2) and von Willebrand factor (vWF) from human umbilical vein endothelial cells (HUVEC) was examined to determine if aprotinin had any effects on these endothelial cell reactions. These end-points were chosen to indicate if this serine protease inhibitor caused alterations in the control of haemostatic function by endothelium, in the light of the improvement in haemostasis seen in patients given aprotinin therapy at the time of open heart surgery. Stimuli used to promote secretion of prostacyclin and vWF were human α-thrombin, histamine, protamine sulphate, poly-L-lysine and phor-bol myristate acetate. Aprotinin (30 pM) had no significant effect on the basal or stimulated release of PGI2 or vWF from HUVEC.

 

  • References

  • 1 Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on the need for blood transfusion after repeat open heart surgery. Lancet 1987; ii: 1289-1291
    PubMedGoogle Scholar
  • 2 Bidstrup BP, Royston D, Taylor KM, Sapsford RN. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989; 97: 364-372
    PubMedGoogle Scholar
  • 3 van Oeveren W, Jansen NJ, Bidstrup BP, Royston D, Westaby S, Neuhof H, Wildevuur CR. Effects of aprotinin on haemostatic mechanisms during cardiopulmonary bypass. Ann Thorac Surg 1987; 44: 640-645
    CrossrefPubMedGoogle Scholar
  • 4 Freidrich G, Weber C, Bernard C, Hettwer A, Schlosser V. Reduction of blood transfusion requirement in open heart surgery by administration of high dose aprotinin - preliminary results. Thorac Cardiovasc Surgeon 1989; 37: 89-91
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Nievelstein PFEM, de Groot PG. Interaction of blood platelets with the vessel wall. Haemostasis 1988; 18: 342-359
    PubMedGoogle Scholar
  • 6 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical vein. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2743-2756
    PubMedGoogle Scholar
  • 7 Morgan DML. Oxidised poly amines and the growth of human vascular endothelial cells. Prevention of cytotoxic effects by selective acetylation. Biochem J 1987; 242: 347-352
    CrossrefPubMedGoogle Scholar
  • 8 Harper JF. Peritz’ F test: BASIC program of a robust multiple comparison test for statistical analysis of all differences among group means. Comput Biol Med 1984; 142: 437-445
    PubMedGoogle Scholar
  • 9 Coade SB, van Haaren E, Loizou S, Walport MJ, Denham AM, Pearson JD. Endothelial prostacyclin release in systemic lupus erythematosus. Thromb Haemostas 1989; 61: 97-100
    PubMedGoogle Scholar
  • 10 Ager A, Gordon JL, Moncada S, Pearson JD, Salmon JA, Trevethick MA. Effects of isolation and culture on prostaglandin synthesis by porcine aortic endothelial and smooth muscle cells. J Cell Physiol 1987; 110: 9-16
    PubMedGoogle Scholar
  • 11 Pottinger BE, Paleolog EM, Pearson JD. Von Willebrand factor is an acute phase reactant in man. Thromb Res 1989; 53: 387-394
    CrossrefPubMedGoogle Scholar
  • 12 Petty RG, Pearson JD. Endothelium - the axis of vascular health and disease. J R Coll Phys (Lond) 1989; 23: 92-102
    PubMedGoogle Scholar
  • 13 Ruggeri ZM, Mannucci PM, Lombardi R, Federici AB, Zimmerman TS. Multimeric composition of factor VIII/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy of von Willebrand’s disease subtypes. Blood 1982; 59: 1272-1278
    PubMedGoogle Scholar
  • 14 Salzman EW, Weinstein MJ, Weintraub RM, Ware JA, Thurer RL, Robertson L, Donovan A, Gaffney T, Bertele V, Troll J, Smith M, Chute LE. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. N Engl J Med 1986; 314: 1402-1406
    CrossrefPubMedGoogle Scholar
  • 15 Fish KJ, Sarnquist FH, van Steennis C, Mitchell RS, Hilberman M, Jamieson SW, Linet OI, Miller DC. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. J Thorac Cardiovasc Surg 1986; 91: 436-442
    PubMedGoogle Scholar
  • 16 Dietrich W, Spannagl M, Jochum M, Wendt P, Scramm W, Barankay A, Sebening F, Richter JA. Influence of high dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology 1990; 73: 1119-1126
    CrossrefPubMedGoogle Scholar
  • 17 Marath A, Man W, Taylor KM. Histamine release in paediatric cardiopulmonary bypass - a possible role in the capillary leak syndrome. Agents Actions 1987; 20: 299-302
    CrossrefPubMedGoogle Scholar
  • 18 Weksler BB, Ley CW, Jaffe EA. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin and the ionophore A23187. J Clin Invest 1978; 62: 923-930
    CrossrefPubMedGoogle Scholar
  • 19 Hamilton KK, Sims PJ. Changes in cytosolic Ca2+ associated with von Willebrand factor release in human endothelial cells exposed to histamine. J Clin Invest 1987; 79: 600-608
    CrossrefPubMedGoogle Scholar
  • 20 Loesberg C, Gonsalves MD, Zandbergen J, Willems C, van Aken WG. The effect of calcium on the secretion of factor VUI-related antigen by cultured human endothelial cells. Biochim Biophys Acta 1983; 763: 160-168
    CrossrefPubMedGoogle Scholar
  • 21 Needham L, Hellewell PG, Williams TJ, Gordon JL. Endothelial functional responses and increased vascular permeability induced by polycations. Lab Invest 1988; 59: 538-548
    PubMedGoogle Scholar
  • 22 Birnbaumer L, Brown AM. G proteins and the mechanism of action of hormones, neurotransmitters and autocrine and paracrine regulatory function. Am Rev Respir Dis 1990; 141: S106-14
    CrossrefPubMedGoogle Scholar
  • 23 Wilks JW, Hui OJ. Aprotinin antagonizes the binding of human chorionic gonadotrophin to its receptor. Endocrinology 1987; 120: 846-952
    PubMedGoogle Scholar
  • 24 Pelikan P, Gimbrone MA, Cotran RS. Distribution and movement of anionic surface sites in cultured human vascular endothelial cells. Atherosclerosis 1979; 32: 69-75
    CrossrefPubMedGoogle Scholar
  • 25 Mizuta K, Hashimoto E, Yamamura H. Proteolytic activation of protein kinase C by membrane-bound protease in rat liver plasma membrane. Biochem Biophys Res Comm 1985; 131: 1262-1268
    CrossrefPubMedGoogle Scholar
  • 26 Giddings JL. Von Willebrand factor-physiology. In: Vascular Endothelium in Hemostasis and Thrombosis. Gimbrone Jr MA. (ed) Churchill Livingstone; Edinburgh: 1986. pp 142-168
    Google Scholar
  • 27 Hamilton KK, Fretto LJ, Grierson DS, McKee PA. Effects of plasmin on von Willebrand Factor multimers. J Clin Invest 1985; 76: 261-270
    CrossrefPubMedGoogle Scholar
  • 28 Thompson AE, Howard MA. Proteolytic cleavage of human von Willebrand Factor induced by enzyme(s) released from polymorphonuclear cells. Blood 1986; 67: 1281-1285
    PubMedGoogle Scholar
  • 29 Radomski MW, Palmer RMJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987; 148: 1482-1489
    CrossrefPubMedGoogle Scholar
  • 30 Sneddon JM, Vane JR. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci 1988; 85: 2800-2804
    CrossrefPubMedGoogle Scholar